NALIN MATHUR: Open Payments
NPI 1891791935 · WALDORF, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$488 in 18 payments from 10 companies in 2025. Trend: 2023 $484 · 2024 $690 · 2025 $488
Food & beverage: $488
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 5 | $207 |
| Amgen Inc. | 2 | $63 |
| GlaxoSmithKline, LLC. | 3 | $52 |
| Corcept Therapeutics | 2 | $47 |
| Novo Nordisk Inc | 1 | $25 |
| PFIZER INC. | 1 | $23 |
| Exact Sciences Corporation | 1 | $22 |
| ABBVIE INC. | 1 | $21 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
| Phathom Pharmaceuticals, Inc. | 1 | $13 |
Products named: FREESTYLE LIBRE 3, TRELEGY ELLIPTA, Korlym, OTEZLA, REPATHA, Rybelsus, PAXLOVID, Cologuard Collection Kit.
Industry payments across MD — which companies pay providers there.
